Abstract
We have earlier reported that γ-hydroxybutyric acid (GHB) disrupts the acquisition of spatial learning and memory in adolescent rats. GHB is known to interact with several neurotransmitter systems that have been implicated in cognitive functioning. The N-methyl-D-aspartate receptor (NR) -type of glutamate receptor is considered to be an important target for spatial learning and memory. Molecular mechanisms governing the neuroadptations following repeated GHB treatment in adolecent rats remain unknown. We examined the role of NMDA receptor in adolescent GHB-induced cognitive deficit. Adolescent rats were administered with GHB on 6 consecutive days, and surface-expressed NMDA receptor subunits levels were measured. GHB significantly decreased NR1 levels in the frontal cortex. Adolescent GHB also significantly reduced cortical NR2A subunit levels. Our findings support the hypothesis that adolescent GHB-induced cogntive deficits are associated with neuroadaptations in glutamatergic transmission, particulaly NR functioning in the frontal cortex.
Keywords: Addiction, juvenile, cognitive function, glutamatergic, radioligand binding, western blot, NR subunit, GHB, presynaptic terminal, NR subunit, GHB, NMDA receptor, NMDA receptor antagonists
Current Neuropharmacology
Title: GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor
Volume: 9 Issue: 1
Author(s): R. Sircar, L-C. Wu, K. Reddy, D. Sircar and A. K. Basak
Affiliation:
Keywords: Addiction, juvenile, cognitive function, glutamatergic, radioligand binding, western blot, NR subunit, GHB, presynaptic terminal, NR subunit, GHB, NMDA receptor, NMDA receptor antagonists
Abstract: We have earlier reported that γ-hydroxybutyric acid (GHB) disrupts the acquisition of spatial learning and memory in adolescent rats. GHB is known to interact with several neurotransmitter systems that have been implicated in cognitive functioning. The N-methyl-D-aspartate receptor (NR) -type of glutamate receptor is considered to be an important target for spatial learning and memory. Molecular mechanisms governing the neuroadptations following repeated GHB treatment in adolecent rats remain unknown. We examined the role of NMDA receptor in adolescent GHB-induced cognitive deficit. Adolescent rats were administered with GHB on 6 consecutive days, and surface-expressed NMDA receptor subunits levels were measured. GHB significantly decreased NR1 levels in the frontal cortex. Adolescent GHB also significantly reduced cortical NR2A subunit levels. Our findings support the hypothesis that adolescent GHB-induced cogntive deficits are associated with neuroadaptations in glutamatergic transmission, particulaly NR functioning in the frontal cortex.
Export Options
About this article
Cite this article as:
Sircar R., Wu L-C., Reddy K., Sircar D. and K. Basak A., GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017038
DOI https://dx.doi.org/10.2174/157015911795017038 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurogenic Inflammation and Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Curcumin and Immunity
Current Bioactive Compounds Genetics in Neural Toxicities of Drugs
Central Nervous System Agents in Medicinal Chemistry Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Current Alzheimer Research Pavlovian Sign-Tracking Model of Alcohol Abuse
Current Drug Abuse Reviews Central Selective Acetylcholinesterase Inhibitor with Neurotrophic Activity Structure-Activity Relationships of TAK-147 and Related Compounds
Current Medicinal Chemistry Apoptosis: A Potential Therapeutic Target for Retinal Degenerations
Current Neurovascular Research Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005
Recent Patents on CNS Drug Discovery (Discontinued) Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice
CNS & Neurological Disorders - Drug Targets Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches
CNS & Neurological Disorders - Drug Targets Nutritional and Therapeutic Potential of Spirulina
Current Pharmaceutical Biotechnology Regulatory Mechanisms of Calcineurin Phosphatase Activity
Current Medicinal Chemistry Small Non-Coding RNAs as Novel Therapeutics
Current Molecular Medicine Anthocyanins: Plant Pigments, Food Ingredients or Therapeutic Agents for the CNS? A Mini-Review Focused on Clinical Trials
Current Pharmaceutical Design Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Antimicrobial Sensitivity Pattern of Bacterial Pathogens in Urinary Tract Infections in South Delhi, India
Reviews on Recent Clinical Trials Formation of Vesicles Through Solvent Assisted Self-Assembly of Hydrophobic Pentapeptides: Encapsulation and pH Responsive Release of Dyes by the Vesicles
Protein & Peptide Letters Application of Proteomics to the Discovery of Cancer Biomarkers
Current Cancer Therapy Reviews Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research The Capsaicin Paradox: Pain Relief by an Algesic Agent
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry